Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7

https://doi.org/10.1016/0006-291X(89)92413-3Get rights and content

Abstract

Regulation of breast tumor proliferation depends in a large part on a variety of hormones and growth factors. In this report we show that estrogen and antiestrogen modulate epidermal growth factor-receptor (EGF-R) level in the human breast cancer MCF-7 cells with opposite mechanisms. Although a short-term treatment (24h to 48h) with estradiol leads to a decrease in EGF-R number, the addition of hormone in cell culture for 5 days increases EGF-R level with a maximal effect observed at 10−10 M estradiol. In contrast, when cells are treated with the antiestrogen hydroxytamoxifen, a dose-dependent decrease in EGF-R level occurs. We also report that EGF is able to induce estrogen receptors and, to a lesser extent, progesterone receptors when added to MCF-7 cell cultures. These results demonstrate an interaction between both estrogen receptor and EGF receptor growth promoting systems in target cells. The implications of such an interaction in the understanding of human breast cancer hormone responsiveness and, in the development of therapies, are discussed.

References (37)

  • S. Bardon et al.

    Mol. Cell. Endocrin

    (1984)
  • K. Mori et al.

    Biochem. Biophys. Res. Comm

    (1988)
  • S.D. Costa et al.

    Biochem. Biophys. Res. Comm

    (1985)
  • L.C. Murphy et al.

    Biochem. Biophys. Res. Comm

    (1988)
  • M. Koga et al.

    Biochem. Biophys. Res. Comm

    (1987)
  • F. Vignon et al.

    Biochem. Biophys. Res. Comm

    (1987)
  • N. Pourreau-Schneider et al.

    J. Steroid Biochem

    (1984)
  • R.T. Hinegardner

    Analyt. Biochem

    (1971)
  • G.P. Rossini

    J. Theor. Biol

    (1984)
  • H. Rochefort

    Trends Pharmacol. Sci

    (1987)
  • J. Massague

    J. Biol. Chem

    (1983)
  • V.R. Mukku et al.

    J. Biol. Chem

    (1985)
  • C. Knabbe et al.

    Cell

    (1987)
  • M.N. Krupp et al.

    J. Biol. Chem

    (1982)
  • C.K. Osborn et al.
  • R.B. Dickson et al.

    Endocrine Review

    (1987)
  • A.M. Soto et al.

    Endocrine Review

    (1987)
  • B.S. Katzenellenbogen et al.

    Cancer Res

    (1984)
  • Cited by (76)

    • Changes in glycosaminoglycans and proteoglycans of normal breast and fibroadenoma during the menstrual cycle

      2012, Biochimica et Biophysica Acta - General Subjects
      Citation Excerpt :

      The estrogen receptor (ER) and the progesterone receptor (PR) belong to the steroid hormone receptor family of ligand inducible transcription factors [5]. These hormones play important roles in the control of proliferation and differentiation of breast cells, but other tissue components and growth factors may also be involved, underlining the complexity of these control mechanisms [6–8]. In all animal tissues, the cells are located in a microenvironment composed of a dynamic and complex array of collagens, glycoproteins, proteoglycans (PGs) and glycosaminoglycans (GAGs)—the extracellular matrix.

    View all citing articles on Scopus
    View full text